These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11553622)

  • 1. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
    Maurice D; Pierreux CE; Howell M; Wilentz RE; Owen MJ; Hill CS
    J Biol Chem; 2001 Nov; 276(46):43175-81. PubMed ID: 11553622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
    De Bosscher K; Hill CS; Nicolás FJ
    Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
    Pierreux CE; Nicolás FJ; Hill CS
    Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
    Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
    J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes.
    Howell M; Itoh F; Pierreux CE; Valgeirsdottir S; Itoh S; ten Dijke P; Hill CS
    Dev Biol; 1999 Oct; 214(2):354-69. PubMed ID: 10525340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.
    Wan M; Tang Y; Tytler EM; Lu C; Jin B; Vickers SM; Yang L; Shi X; Cao X
    J Biol Chem; 2004 Apr; 279(15):14484-7. PubMed ID: 14988407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
    Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
    J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta signaling in colon cancer cells.
    Li F; Cao Y; Townsend CM; Ko TC
    World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
    Kato Y; Habas R; Katsuyama Y; Näär AM; He X
    Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
    Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.
    Wan M; Huang J; Jhala NC; Tytler EM; Yang L; Vickers SM; Tang Y; Lu C; Wang N; Cao X
    Am J Pathol; 2005 May; 166(5):1379-92. PubMed ID: 15855639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.